4.7 Letter

Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee

Harald Hoffmann et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Letter Infectious Diseases

Bedaquiline plus delamanid for XDR tuberculosis

Marie Lachatre et al.

LANCET INFECTIOUS DISEASES (2016)

Letter Medicine, General & Internal

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis

Guido V. Bloemberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)